financetom
Business
financetom
/
Business
/
Palisade Bio Gets Health Canada Clearance to Start Phase 1 Study of PALI-2108 for Treating Ulcerative Colitis
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Palisade Bio Gets Health Canada Clearance to Start Phase 1 Study of PALI-2108 for Treating Ulcerative Colitis
Oct 10, 2024 11:09 PM

10:29 AM EDT, 10/10/2024 (MT Newswires) -- Palisade Bio ( PALI ) said Thursday it has received clearance from Health Canada to start a phase 1 trial that will evaluate PALI-2108 for the treatment of ulcerative colitis.

Preparations for the trial are ongoing and Palisade is on track to begin enrollment before the end of the year, the company said.

Price: 3.31, Change: -0.01, Percent Change: -0.45

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved